Navigation Links
BONESUPPORT sélectionné en tant que 100 meilleures entreprises mondiales du Red Herring 2012
Date:12/6/2012

LUND, Suède, 6 décembre 2012 /PRNewswire/ -- BONESUPPORT, chef de file émergent dans les substituts osseux injectables pour les traumatismes orthopédiques, les infections osseuses et l'augmentation des instruments liés à la chirurgie orthopédique, a annoncé aujourd'hui qu'elle a été sélectionnée comme un vainqueur des 100 meilleures entreprises du prix mondial Red Herring 2012 dans la reconnaissance en tant que leader en matière d'innovation et de technologie parmi les entreprises privées d'Amérique du Nord, d'Europe et d'Asie.  La liste des 100 meilleures entreprises mondiales de Red Herring est devenue une marque de distinction pour identifier de nouvelles entreprises et des entrepreneurs prometteurs.

(Photo: http://photos.prnewswire.com/prnh/20121206/NY24527 )

« Choisir les sociétés avec le plus fort potentiel n'a pas été une mince affaire », a déclaré Alex Vieux, éditeur et président-directeur général de Red Herring. « Après une réflexion et des discussions rigoureuses, nous avons réduit notre liste qui comportait plusieurs centaines de candidats au niveau mondial pour arriver aux vainqueurs des 100 meilleurs. Nous croyons que BONESUPPORT incarne la vision, le dynamisme et l'innovation qui définissent une initiative entrepreneuriale réussie. BONESUPPORT devrait être fière de son accomplissement, car la concurrence était plus forte qu'elle ne l'a jamais été ».

L'équipe de rédaction de Red Herring a évalué les entreprises sur des critères quantitatifs et qualitatifs, tels que la performance financière, l'innovation technologique, la qualité du management, la stratégie et la pén
'/>"/>

SOURCE BONESUPPORT
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. BONESUPPORT Selected As A 2012 Red Herring Top 100 Global
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2015)... 19, 2015  Technology is rapidly advancing, outpacing enterprises, ... the cloud. Passwords and their management are soon to ... standards-based specifications such as those developed by the FIDO ... passwords presents for BYOD, COPE, IoT, and mobile payments, ... protocol. In response to the call ...
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... promising new class of drug designed to target the ... system, some of the HCV strains being treated exhibited ... team of Florida State University biologists, chemists and biomedical ... identify the drug-resistant HCV strains and the molecular-level mechanisms ...
... powerful new ability to engineer the flavor and aroma of ... publishing the most comprehensive deciphering of the beer,s "proteome" ever ... that make beer "beer") appears in ACS, monthly Journal ... say they were inspired to do the research by a ...
... has "significant" potential for preventing cardiomyopathy, a form of heart ... with diabetes, scientists have concluded in a new study. Their ... high risk for diabetic cardiomyopathy, appears in ACS, bi-weekly ... and colleagues note that people with diabetes have at least ...
Cached Biology News:Hepatitis C virus faces new weapon from Florida State scientists 2Hepatitis C virus faces new weapon from Florida State scientists 3
(Date:5/21/2015)... , May 21, 2015  The EveryLife Foundation ... (R-UT) and Amy Klobuchar (D-MN) ... Accelerating Cures & Treatments, or OPEN ACT. ... patient advocacy organizations, this bipartisan legislation promises to ... medicines to rare disease patients by incentivizing drug ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 20, 2015 Research and Markets ... the "2015 Global Survey on Flow Cytometry ... The primary goal of this research is ... and reagents. Key information the survey seeks to ... flow cytometers, predominantly used applications for flow cytometers, ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
... Feb. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences ... that on February 2, 2009 it received a letter ... the Company that the Panel has determined to grant ... Capital Market. The Panel granted the Company through ...
... CRY ), a biomaterials, medical device and tissue ... end financial results will be released on Thursday, February 19, ... live webcast at 10:00 a.m. Eastern Time, February 19, 2009, ... session hosted by Steven G. Anderson, president and CEO of ...
... first kidney-targeted antisense drug for type 2 diabetes enters ... (Nasdaq: ISIS ) announced today it has ... drug that inhibits the production of sodium dependent glucose ... transporter responsible for glucose re-absorption in the kidney. ...
Cached Biology Technology:Nasdaq Panel Grants Advanced Life Sciences Request for Continued Listing on Nasdaq Stock Market 2CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results 2Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug 2Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug 3Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug 4
...
Request Info...
Human RUNX2/CBFA1 MAb (Clone 232902)...
... Streptavidin-Horseradish Peroxidase Conjugate, ... to reporter enzyme molecules ... and in situ hybridization ... Blotting & Labeling & ...
Biology Products: